Dr. Mark Pidkowich is a partner in Smart & Biggar's Vancouver office. His practice focusses on the development and management of patent portfolios in the chemical and life sciences, including biologics, drug discovery, diagnostics and medical devices, and natural products. Mark represents clients in respect of their intellectual property transactions, including licenses, acquisitions and research and development agreements. Mark regularly prepares international patent applications and advises clients throughout subsequent patent prosecution in various jurisdictions, including Canada, Europe, the United States and Australia. He also prosecutes Canadian patent applications for clients in the United States, Europe and other jurisdictions. Mark has successfully represented clients before the Patent Appeal Board.
After obtaining a Ph.D. in developmental genetics from the University of British Columbia, Mark was a research associate at Brookhaven National Laboratory where he worked on the metabolic engineering of designer oils in oilseed crops. He has also worked on the molecular farming of enzyme therapies for rare metabolic disorders. Mark's work has been published in several peer-reviewed journals including the Proceedings of the National Academy of Sciences (U.S.A.), and patented as US 9,340,776.
Mark is currently co-chair of the AIPLA's Plant Biotechnology Subcommittee, Co-chair of the American Intellectual Property Law Association Plant Biotechnology Subcommittee and an associate of Intellectual Property Institute of Canada.
Mark is named in Best Lawyers in Canada 2018 for Intellectual Property Law. He has also been recognized in LMG Rising Stars under Life Sciences since 2015.
He was called to the British Columbia bar in 2009.